DIA
Drug Information Association Logo

#33: Understanding Comparative Effectiveness Research (CER) in the Biopharmaceutical Industry

Tutorial name:
#33: Understanding Comparative Effectiveness Research (CER) in the Biopharmaceutical Industry

Day & Time:
June 24, 1:00PM - 4:30PM

Room Number:
121AB

Description:
Maximize your learning while attending the DIA 2012 Annual Meeting! Receive $100 off of your DIA 2012 meeting registration by registering for two half day tutorials (#20-34) or one full day tutorial (#40-48). Purchases must be made at the same time in order to receive the discount.

Health care reform has amplified interest in Comparative Effectiveness Research (CER) / Health Technology Assessment (HTA). CER/HTA may sound threatening without a realistic context for what it is, how it has evolved, what it is intended to do and its limitations. A brief introduction and overview of CER/HTA will be presented through lecture, interactive discussions and case study. This tutorial will present a perspective of CER/HTA in the context of clinical trials and health care policy and provide timely insights for today’s biopharmaceutical professionals.

This tutorial will provide:
• An introduction to origins of CER/HTA and key terminology and concepts
• Overview of some of the entities with responsibility for CER/HTA
• A brief review of current literature
• Components of CER/HTA using a case study as an example
• Recommended resources for continued learning.


Learning Objective(s):
At the conclusion of this tutorial, attendees should be able to:

• Describe the origins of the models for conducting Comparative Effectiveness Research (CER)/ Health Technology Assessment (HTA)

• Identify methodological problems and solutions in developing the evidence base and the role of CER/HTA.

• Discuss CER/HTA examples applicable to the biopharmaceutical industry



© 2015 DIA